Abstract:Abstract Angelica gigas Nakai (AGN) ethanol extract and its major component decursin have been reported to exert anti-cancer activities. Recently, our team reported that AGN was able to significantly suppress prostate neuroendocrine (NE) carcinogenesis in the TRAMP mice (Proc AACR, 2011, #5581). To gain insights into the in vivo mechanism(s) and potential targets, we used a systems-biology approach with a combination of proteomics and transcriptomics to analyze banked NE carcinoma tissues from vehicle- and AGN-treated groups (from 8 to 24 weeks of age). Global profiling of the proteome was performed by LC-MS/MS with iTRAQ labeling whereas the transcriptome was profiled by Illumina Mouse WG-6 BeadChip whole genome expression array. Angiogenesis Antibody Arrays (RayBiotech) were used to analyze angiogenesis-related proteins as a focused approach. Differentially expressed mRNA and proteins were subjected to bioinformatics analysis with Ingenuity Pathway Analysis (IPA). Antibody array analyses revealed that FGF2, a crucial stimulator of angiogenesis and promoter of tumor growth, was substantially decreased by AGN treatment. Other FGF family member such as FGF10, an oncogenic protein expressed in stromal cells, was also decreased by AGN at the mRNA level by more than 50%. In addition, mining of the microarray and proteomics data indicated that the changes of genes upstream and downstream of FGF2 were functionally consistent with AGN inhibiting FGF2/FGFR1 signaling at different levels of the transduction cascade. For example, FGFR1 mRNA level was decreased by AGN; FGFBP3, a binding protein which can protect FGFs from degradation, was decreased at the mRNA level; Dipeptidyl peptidase IV, which can block FGF2 signaling pathway in prostate cancer cells, was increased by AGN; “Good” stromal markers Myh11 and Myh4 which could be suppressed in FGF2 signaling pathway through Ras and ERK were substantially increased by AGN at both mRNA and protein levels. Some changes in mRNA levels suggested an anti-invasion potential of AGN. For example, the mRNA levels for urokinase plasminogen activator, Col1a1, Col1a2, MMP2, MMP3 and MMP12 were all decreased by AGN; Tropomyosin 2, reported to reduce the motility and invasion of cancer cells, was induced by AGN. Moreover, AGN up-regulated E-cadherin and down-regulated vimentin at both mRNA and protein levels, suggesting an anti-EMT action. IPA identified Akt, PI3K, p38MAPK, and ERK1/2 as distinct inferred network nodes after analyzing all AGN-responding genes. Furthermore, a number of genes down-regulated during TRAMP carcinogenesis such as Msmb, Actc1, Csrp1 and GSTM1 were increased by AGN treatment at protein and/or mRNA levels. Given the anti-angiogenesis, anti-invasion and anti-EMT effects of AGN observed, its anti-cancer activities may in part be mediated by affecting the tumor micro-environment in addition to cancer cells. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2587. doi:1538-7445.AM2012-2587

Angelol-A exerts anti-metastatic and anti-angiogenic effects on human cervical carcinoma cells by modulating the phosphorylated-ERK/miR-29a-3p that targets the MMP2/VEGFA axis

Angelica stimulates proliferation of murine bone marrow mononuclear cells by the MAPK pathway.

Angelica Sinensis Suppresses Human Lung Adenocarcinoma A549 Cell Metastasis by Regulating MMPs/TIMPs and TGF-β1.

Angelicin inhibits the malignant behaviours of human cervical cancer potentially via inhibiting autophagy

Abstract 2587: Proteomic and Transcriptomic Profiling of Effects of Angelica Gigas Ethanol Extract on Prostate Neuroendocrine Carcinomas of TRAMP Mice

Andrographolide Inhibits Tumor Angiogenesis Via Blocking VEGFA/VEGFR2-MAPKs Signaling Cascade

Anti-oxidant and anti-cancer activities of Angelica dahurica extract via induction of apoptosis in colon cancer cells

Angelicin Shows Antitumor Effects On The Oral Squamous Cell Carcinoma By Negatively Regulating DUSP6-Mediated cMYC-MAPK Signaling Pathway

Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.

A comprehensive review of antitumor properties of Angelica species and their antitumor‐responsible constituents and the underlying molecular mechanisms involved in tumor inhibition

Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis.

Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway

Effect of AAD Anti-Tumor on Mice Bearing in U14 Cervical Cancer

Acetylation and Amination Protect Angiotensin 1-7 from Physiological Hydrolyzation and Therefore Increases Its Antitumor Effects on Lung Cancer

Recombinant Adeno-Associated Virus-Delivered Anginex Inhibits Angiogenesis and Growth of HUVECs by Regulating the Akt, JNK and NF-κB Signaling Pathways.

ASC, a Bioactive Steroidal Saponin from Ophitopogin Japonicas, Inhibits Angiogenesis Through Interruption of Src Tyrosine Kinase‐dependent Matrix Metalloproteinase Pathway

Effect of Angelica Extract on the Endothelial Cell Migration and Expression of Gelatinases

Effects of angiopoietin 2 single-chain antibody on human hepatocellular carcinoma in nude mice

Experimental study of Angelica Pubescens and Osthole isolated from Angelica Pubescens inhibiting angiogenesis in vitro

Study of Biological Effect of Angiopoietin-1 on Human Gastric Cancer Cell in Vitro

Angelicin inhibits liver cancer growth in vitro and in vivo